Cohort Studyhigh evidence
Anti-Mullerian Hormone and Collagen Type I C-telopeptide Predict Fast, Imminent Bone Loss in Early Perimenopause: SWAN.
The Journal of clinical endocrinology and metabolism·May 19, 2026·PMID 41399290
Why it mattersIdentifying women at highest risk for rapid bone loss near menopause could enable earlier, targeted interventions to prevent osteoporosis and fractures. This study provides a practical dual-biomarker approach that outperforms single markers.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled